Indivior (INDV)

 

Latest News

Holding(s) in Company

RNS Number: 8494N Indivior PLC 14 August 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Indivior Plc 1b. Please ind...

Broker Forecast - Jefferies International issues a broker note on Indivior Plc

Jefferies International today reaffirms its buy investment rating on Indivior Plc (LON:INDV) and raised its price target to...

Director/PDMR Shareholding (Replacement)

RNS Number: 7081N Indivior PLC 10 August 2017 The 'Director/PDMR Shareholding ' announcement for Indivior PLC released on 10 th August at 16:00 under RNS No 7059N has been re-released to facilitate onward transmission by third party vendors. The announcement is unchanged and is reproduced in full below. Indivior PLC (the 'Company') Notification and p...

Director/PDMR Shareholding

RNS Number: 7059N Indivior PLC 10 August 2017 Indivior PLC (the 'Company') Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them. The Company has a sponsored Level 1 American Depositary Receipt (ADR) facility in the United States, with each ADR representing five ordina...

All News

DateHeadlineSource
14-08-17Holding(s) in CompanyRNS
11-08-17Broker Forecast - Jefferies International issues a broker note on Indivior PlcStockMarketWire
10-08-17Director/PDMR Shareholding (Replacement)RNS
10-08-17Director/PDMR ShareholdingRNS
08-08-17Holding(s) in CompanyRNS
08-08-17Holding(s) in CompanyRNS
08-08-17Holding(s) in CompanyRNS
08-08-17Holding(s) in CompanyRNS
02-08-17Holding(s) in CompanyRNS
01-08-17Total Voting RightsRNS
31-07-17Holding(s) in CompanyRNS
31-07-17Indivior drug receives FDA priority reviewStockMarketWire
31-07-17Indivior's NALSCUE? Receives ANSM MA for FranceRNS
31-07-17RBP-6000 NDA Receives FDA Priority ReviewRNS
28-07-17Share of the Week: This healthcare small-cap could trebleInteractive Investor
27-07-17FTSE slides lower after AstraZeneca crashStockMarketWire
27-07-17Half Year Financial ResultsRNS
13-07-17Indivior sets date of H1 results announcementStockMarketWire
13-07-17Notice of ResultsRNS
29-06-17RBP-6000 Investor Event ReminderRNS
16-06-17RBP-6000 Investor EventRNS
02-06-17Block Listing Six Monthly ReturnRNS
01-06-17Total Voting RightsRNS
30-05-17RBP-6000 - Submission of NDA to U.S. FDARNS
23-05-17Jefferies Global Healthcare ConferenceRNS
18-05-17Indivior resolutions passed at AGMStockMarketWire
17-05-17Result of AGMRNS
03-05-17Indivior Q1 profit, revenue up in Q1StockMarketWire
03-05-171st Quarter ResultsRNS
19-04-17Indivior schedules Q1 results announcementStockMarketWire
19-04-17Notice of ResultsRNS
07-04-17Holding(s) in CompanyRNS
28-03-17Additional RBP-6000 Clinical Study ResultsRNS
23-03-17Indivior sets date for AGMStockMarketWire
23-03-17Annual Financial ReportRNS
13-03-17Top-line Phase 3 Trial Results - RBP-7000RNS
13-03-17Broker Forecast - RBC Capital Markets issues a broker note on Indivior PlcStockMarketWire
08-03-17Indivior CFO steps down StockMarketWire
07-03-17Director ResignationRNS
02-03-17Broker Forecast - Citigroup issues a broker note on Indivior PlcStockMarketWire

RSS feeds

  • Editorial news feed for LSE:INDV Editorial
  • Regulatory news feed for LSE:INDV Regulatory